Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
National Journal of Andrology ; (12): 447-457, 2015.
Artigo em Chinês | WPRIM | ID: wpr-276076

RESUMO

<p><b>OBJECTIVE</b>To evaluate the clinical efficacy and safety of phosphodiesterase 5 (PDE-5) inhibitors for erectile dysfunction (ED) in patients with diabetes mellitus and provide some evidence for the clinical treatment of the disease.</p><p><b>METHODS</b>We searched MedMed, EMbase, Cochrane Library, CNKI, Wan Fang Data, VIP and ZADL for randomized controlled trials on PDE-5 inhibitors for ED in diabetic men and evaluated the methodology of the included trials with the Jadad scale. We used the erectile function domain in the IIEF (IIEF-EF), IIEF questions (IIEF-Q) 3 and 4, SEP-2 and -3, and Global Assessment Questions (GAQ) as the main evaluation indexes and employed the Review Manager 5. 1. 0 software for meta analysis.</p><p><b>RESULTS</b>A total of 13 studies were included, which were all high quality trials with Jadad score > 3. The IIEF-EF scores in 10 of the included studies were subjected to meta analysis using the random-effect model (REM), with a weighted mean difference (WMD) of 5.64 (95% CI 4.41 - 6.83, P < 0.001). The fixed-effect model (FEM) analysis of the IIEF-Q scores in 6 of the studies showed the WMD to be 0.96 (95% CI 0.83 -1.08, P < 0.001) for IIEF-Q3 and 1.11 (95% CI 0.98 - 1.25, P < 0.001) for IIEF-Q4. FEM analysis of the SEP-2 scores showed WMD = 17.67 (95% CI 12. 38 - 22. 97, P < 0.001) in 2 of the studies, and that of the SEP-3 scores WMD = 23.64 (95% CI 17. 49 - 29.79, P < 0.001) in 5 of the studies. The GAQ scores in 11 of the studies were subjected to REM analysis, with OR = 6. 20 and 95% CI 3.65 - 10.52 (P < 0.001). REM analysis was performed on the adverse reactions in 11 of the studies, with OR = 7.43 and 95% CI 4.11 - 13.44 (P < 0.001).</p><p><b>CONCLUSION</b>PDE-5 inhibitors can effectively and safely improve erectile function in patients with diabetes mellitus.</p>


Assuntos
Humanos , Masculino , Diabetes Mellitus , Disfunção Erétil , Tratamento Farmacológico , Gangliosídeos , Ereção Peniana , Inibidores da Fosfodiesterase 5 , Usos Terapêuticos
2.
National Journal of Andrology ; (12): 897-901, 2011.
Artigo em Chinês | WPRIM | ID: wpr-305768

RESUMO

<p><b>OBJECTIVE</b>To investigate the effect of high ligation of the spermatic vein (HLSV) on DNA fragmentation in varicocele (VC) patients.</p><p><b>METHODS</b>Thirty-four VC patients underwent HLSV. Sperm motion indexes and the results of papanicolaou staining and DNA fragmentation detection were analyzed before and 3 months after the operation according to the WHO guidelines.</p><p><b>RESULTS</b>Compared with pre-operation, HLSV achieved a significant increase in the percentage of morphologically normal sperm (P < 0.01), and remarkable decreases in DNA fragmentation, sperm deformity index (SDI) and multiple anomalies index (MAI) (P < 0.01). The patients also showed significant increases in sperm concentration and the percentages of grade b sperm (P < 0.05) and grade a and a + b sperm (P < 0.01) after the operation. The post-operative percentages of sperm DNA fragmentation in those with grades I - III VC were markedly lower (P < 0.01), but showed no significant difference from that in those with subclinical VC (P > 0.05). The percentage of big-halo sperm was significantly increased (P < 0.01), while those of the medium-, small- and non-halo sperm remarkably decreased (P < 0.01) after HLSV.</p><p><b>CONCLUSION</b>HLSV can effectively improve the sperm quality of VC patients.</p>


Assuntos
Adolescente , Adulto , Humanos , Masculino , Adulto Jovem , Fragmentação do DNA , Ligadura , Métodos , Contagem de Espermatozoides , Motilidade dos Espermatozoides , Espermatozoides , Fisiologia , Varicocele , Genética , Cirurgia Geral , Veias , Cirurgia Geral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA